<html><body><p>Italian chemical giant Montedison S.p.A., through its Montedison Acquisition N.V. indirect unit , began its $ 37-a-share tender offer for all the common shares outstanding of Erbamont N.V., a maker of pharmaceuticals incorporated in the Netherlands . The offer , advertised in today 's editions of The Wall Street Journal , is scheduled to expire at the the end of November . Montedison currently owns about 72 % of Erbamont 's common shares outstanding . The offer is being <span style='background:yellow'>launched</span> pursuant to a previously announced <span style='background:yellow'>agreement</span> between the companies .</p></body></html>